Ms Morgaine Wallace-Steele's blog
Dr Jacques Raubenheimer from The University of Sydney presented at the 2019 NDARC Seminar Series on Thursday, 11 April 2019.
Professor Emmanuel Kuntsche from the Centre for Alcohol Policy Research (CAPR) presented at the 2019 NDARC Seminar Series on Thursday, 28 March 2019.
About the presentation:
Professor Shane Darke from the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney presented at the 2019 NDARC Seminar Series on Thursday, 14 March 2019.
About the presentation:
The 2019 NDARC Seminar Series commenced on Tuesday, 19 February 2019 with a special presentation by Professor David Nutt from Imperial College London.
Professor Nutt presented, Addiction: From brain mechanisms to new treatments.
In the last twenty years there have been substantial increases in the use of pharmaceutical opioids in many countries, including Australia which has one of the highest levels of opioid utilisation globally 1. Almost 15 million opioid prescriptions were dispensed in 2015 and our use of high-potency opioids has also increased 2. One of the main drivers is the increased use of prescription opioids for chronic non-caner pain (CNCP) 3. In parallel to escalating use, opioid-related harms have also increased.
The advent of novel extended release depot buprenorphine formulations has the potential to transform opiate substitution therapy in a variety of settings and benefit the lives of people living with opioid dependence. CoLAB is an open-label cohort study of depot buprenorphine evaluating patient outcomes and process, and cost implications in a variety of models of care.
Co-occurring mental health and substance use disorders are common, are harmful to people’s wellbeing and social functioning, and are associated with disproportionately high costs to healthcare systems 1-9. The prevalence of co-occurring disorders in mental health (MH) and Alcohol and other Drug (AoD) treatment settings is sufficiently high that they are described as an ‘expectation rather than an exception’ 3.
The impact of research that actively engages with communities, non-government organisations and clinical services can be fundamentally influenced by the engagement processes that researchers devise and implement. The corollary of this proposition is that establishing a pragmatic, or even evidence-based, process of change is likely to improve outcomes for communities and clients of services. So is it feasible to establish an evidence-based process for engaging communities and services in research?